Magnetic silk fibroin e-gel scaffolds for bone tissue engineering applications
Source abstract
Abstract
Recently, the incorporation of magnetic nanoparticles into standard scaffolds has emerged as a promising approach for tissue engineering applications. This strategy can promote not only tissue regeneration but also reloading of scaffolds through an external supervising center that adsorbs growth factors, preserving their stability and biological activity. In this study, novel magnetic silk fibroin e-gel scaffolds were prepared by the electrogelation process of concentrated Bombyx mori silk fibroin (8 wt%) aqueous solution. In addition, basic fibroblast growth factor was conjugated physically to human serum albumin = Fe 3 O 4 nanoparticles (71.52 ± 2.3 nm in size) with 97.5% binding yield. Scanning electron microscopy images of the prepared human serum albumin = Fe 3 O 4 -basic fibroblast growth factor-loaded silk fibroin e-gel scaffolds showed a three-dimensional porous morphology. In terms of water uptake, basic fibroblast growth factor-conjugated scaffolds had the highest water absorbability among all groups. In vitro cell culture studies showed that both the human serum albumin coating of Fe 3 O 4 nanoparticle surface and basic fibroblast growth factor conjugation had an inductive effect on cell viability. One of the most used markers of bone formation and osteoblast differentiation is alkaline phosphatase activity; human serum albumin = Fe 3 O 4 -basic fibroblast growth factor-loaded silk fibroin e-gels showed significantly enhanced alkaline phosphatase activity (p < 0.05). SaOS-2 cells cultured on human serum albumin = Fe 3 O 4 -basic fibroblast growth factor-loaded silk fibroin e-gels deposited more calcium compared with those cultured on bare silk fibroin e-gels. These results indicated that the proposed e-gel scaffolds are valuable candidates for magnetic guiding in bone tissue regeneration, and they will present new perspectives for magnetic field application in regenerative medicine.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Silk-based biomaterials and applications · Bone Tissue Engineering Materials · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Biology Division, Aksaray University, Aksaray, Turkey
Pharmaceuticals and Medical Devices Agency, Ankara, Turkey
Advanced Technologies Research and Application Center, Hacettepe University, Ankara, Turkey
Biochemistry Division, Department of Chemistry, Hacettepe University, Ankara, Turkey
References (50)
Show source-provided references
1. 10.1016/j.injury.2011.06.01110.1016/j.injury.2011.06.011 ↗
2. Khan WS · Stem Cell Int · 2012 · 236231 · 1
3. 10.1007/s00167-011-1655-110.1007/s00167-011-1655-1 ↗
4. 10.1098/rsif.2014.030510.1098/rsif.2014.0305 ↗
5. 10.1016/j.progpolymsci.2007.05.01310.1016/j.progpolymsci.2007.05.013 ↗
6. 10.1002/adma.20090264310.1002/adma.200902643 ↗
7. 10.1016/j.actbio.2011.02.03210.1016/j.actbio.2011.02.032 ↗
8. 10.1002/mabi.20080005710.1002/mabi.200800057 ↗
9. 10.1021/bm034546010.1021/bm0345460 ↗
10. 10.1021/acsami.5b0230810.1021/acsami.5b02308 ↗
11. 10.1002/jbm.b.3168610.1002/jbm.b.31686 ↗
12. 10.1039/b916319k10.1039/b916319k ↗
13. 10.1177/088391151037438410.1177/0883911510374384 ↗
14. 10.1039/c2sm25783a10.1039/c2sm25783a ↗
15. 10.1016/j.jsb.2009.12.01210.1016/j.jsb.2009.12.012 ↗
16. 10.1021/bm400489210.1021/bm4004892 ↗
17. 10.1016/j.jmmm.2006.11.08110.1016/j.jmmm.2006.11.081 ↗
18. 10.1016/j.biomaterials.2011.01.01910.1016/j.biomaterials.2011.01.019 ↗
19. 10.1016/j.devcel.2005.12.00610.1016/j.devcel.2005.12.006 ↗
20. 10.1177/0022034592071012130110.1177/00220345920710121301 ↗
21. 10.1359/jbmr.2002.17.10.181410.1359/jbmr.2002.17.10.1814 ↗
22. 10.1098/rsif.2008.007110.1098/rsif.2008.0071 ↗
23. 10.1016/j.expneurol.2007.08.00410.1016/j.expneurol.2007.08.004 ↗
24. 10.1089/ten.tea.2009.010010.1089/ten.tea.2009.0100 ↗
25. 10.4061/2010/21814210.4061/2010/218142 ↗
26. 10.1002/jbmr.565006120610.1002/jbmr.5650061206 ↗
27. 10.1016/S0142-9612(03)00354-510.1016/S0142-9612(03)00354-5 ↗
28. 10.1210/edrv.18.1.029210.1210/edrv.18.1.0292 ↗
29. 10.4015/S101623720600018X10.4015/S101623720600018X ↗
30. 10.1007/s00068-006-6047-810.1007/s00068-006-6047-8 ↗
31. 10.1016/j.bone.2008.06.01910.1016/j.bone.2008.06.019 ↗
32. 10.1016/j.actbio.2009.09.01710.1016/j.actbio.2009.09.017 ↗
33. 10.1016/j.biomaterials.2016.01.03510.1016/j.biomaterials.2016.01.035 ↗
34. 10.1038/nprot.2011.37910.1038/nprot.2011.379 ↗
35. 10.1016/j.cap.2009.10.00210.1016/j.cap.2009.10.002 ↗
36. 10.1039/b718745a10.1039/b718745a ↗
37. 10.1016/j.msec.2006.12.01610.1016/j.msec.2006.12.016 ↗
38. 10.1039/C4RA06621A10.1039/C4RA06621A ↗
39. 10.1016/j.jconrel.2007.04.00210.1016/j.jconrel.2007.04.002 ↗
40. 10.1098/rsif.2012.083310.1098/rsif.2012.0833 ↗
41. 10.1371/journal.pone.009158410.1371/journal.pone.0091584 ↗
42. 10.1088/0957-4484/26/12/12510310.1088/0957-4484/26/12/125103 ↗
43. 10.2147/IJN.S2653310.2147/IJN.S26533 ↗
44. 10.1016/j.msec.2005.06.06210.1016/j.msec.2005.06.062 ↗
45. 10.1016/j.bone.2008.07.18510.1016/j.bone.2008.07.185 ↗
46. 10.1039/C5RA07219K10.1039/C5RA07219K ↗
47. Dyondi D · Int J Nanomedicine · 2013 · 8 · 47
48. Santana RB · Int J Oral Maxillofac Implants · 2006 · 21 · 711
49. 10.1016/j.diff.2009.11.00110.1016/j.diff.2009.11.001 ↗
50. 10.1016/j.biomaterials.2010.01.00410.1016/j.biomaterials.2010.01.004 ↗